Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
NCT04062006
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Polymyalgia Rheumatica
Interventions
DRUG:
Interleukin-2
Sponsor
Peking University People's Hospital